Employer Drug Testing Services and Workplace Drug Testing Programs

Employer drug testing is the collection and analysis of a biological specimen to identify the presence or absence of specified drugs or drug metabolites in connection with employment. Testing may occur during hiring, randomly, following certain incidents, based on reasonable suspicion, or under other circumstances permitted by applicable regulations, laws, and company policy.

Many employers may implement workplace drug testing, but the rules differ by state, industry, position, testing reason, and regulatory status. DOT-regulated employers must follow applicable federal requirements. Non-DOT employers should review state and local laws before implementing or changing a testing program.

A written policy is strongly recommended and may be required by applicable law, regulation, contract, or voluntary Drug-Free Workplace Program. A policy helps communicate expectations, establish procedures, and support consistent administration.

Employers frequently conduct pre-employment testing after making a conditional offer and before the applicant begins work. The timing and process should comply with applicable laws and the employer’s established hiring policy.

DOT-regulated employers must conduct random testing when required by the applicable operating agency. Non-DOT random testing may be permitted, restricted, or subject to special requirements depending on state law and the positions being tested.

Employees should be selected using an impartial random-selection process in which each covered participant has an appropriate chance of selection. DOT programs must also comply with applicable selection periods, testing rates, and regulatory requirements.

Reasonable suspicion testing may occur when an authorized supervisor observes specific, current, and articulable indicators that are consistent with possible drug use or alcohol misuse. Decisions should follow company policy and applicable legal or regulatory requirements.

Post-accident testing may be conducted when authorized by applicable regulations, state law, and company policy. DOT post-accident requirements vary by transportation agency and qualifying event. Non-DOT employers should use objective criteria and avoid practices that could discourage injury reporting.

DOT testing is governed by federal regulations, including 49 CFR Part 40 and the applicable DOT agency rules. Non-DOT testing is conducted under employer policy and applicable state or local law. DOT and non-DOT tests should be ordered, documented, and administered as separate programs.

Depending on the program and applicable law, workplace testing may use urine, hair, oral fluid, or another authorized specimen. DOT testing may only use specimen types and procedures permitted under current federal requirements.

No. An instant test generally provides a preliminary screening result at or near the collection location. Laboratory testing uses analytical procedures performed by a laboratory and may include confirmation testing and Medical Review Officer review. Applicable law or policy may require laboratory confirmation before employment action is taken.

A Medical Review Officer, commonly called an MRO, is a qualified physician who reviews certain drug-testing laboratory results and evaluates whether a legitimate medical explanation may exist before reporting a verified result under the applicable testing process.

Timing depends on the specimen, panel, collection location, laboratory process, result, confirmation requirements, and MRO review. Straightforward negative laboratory results are generally completed faster than results requiring additional analysis or donor contact.

Marijuana testing may be included in an employer’s panel, but state and local laws may affect when employers may test, which positions may be covered, and what employment actions may be taken. Employers should evaluate the laws applicable to each work location.

Not necessarily. Legalization and medical-marijuana laws do not create one uniform employment rule. Employer rights, employee protections, safety-sensitive exceptions, disability considerations, and testing restrictions vary by jurisdiction.

Drug-testing records should be handled as confidential information and disclosed only as permitted or required by applicable law, regulation, and company procedure. Employers should use secure reporting, storage, and access controls.

Yes. Workplace testing programs can be established for businesses of nearly any size. Accredited Drug Testing’s invoiced employer account program has separate eligibility requirements; businesses that do not qualify may still order testing services as needed.

Yes. A nationwide testing program can coordinate collections for employees in multiple locations. Employers should ensure their policies and procedures account for the laws applicable in each state or locality.

The employer establishes an account or places an order, selects the testing reason and service, provides the necessary employee information, and directs the employee to an authorized collection location. Results are then reported through the appropriate secure process.

Cost depends on the specimen type, drug panel, DOT or non-DOT status, laboratory services, collection requirements, MRO review, location, volume, and program-management services. Employers should request pricing based on their specific workforce and testing needs.